H1B Report
Side-by-side comparison

Charles River Laboratories, Inc. vs Deloitte Consulting LLP

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Charles River Laboratories, Inc.
MARank #FEIN 76-0509980
Entity B
Deloitte Consulting LLP
PARank #4FEIN 06-1454513

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricCharles River Laboratories, Inc.Deloitte Consulting LLP
Total filings23879,212
Certified %85.71%98.22%
Denied %0.00%1.09%
Withdrawn %1.26%0.61%
Cert-withdrawn %13.03%0.07%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite stateMAPA

Outcomes — Charles River Laboratories, Inc.

DOL case-status mix.

Outcome breakdown: Certified 85.7%, Cert-withdrawn 13.0%, Withdrawn 1.3%
Outcome breakdown
OutcomeShare
Certified85.7%
Cert-withdrawn13.0%
Withdrawn1.3%
Certified85.7%
Cert-withdrawn13.0%
Withdrawn1.3%

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Charles River Laboratories, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201112
FY20122
FY20134
FY20148
FY20157
FY201622
FY201714
FY201818
FY201920
FY20202
FY20211
FY20222
FY20238
FY202445
FY202553
FY202610
Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,357
FY20113,610
FY20124,667
FY20136,024
FY20146,873
FY20157,505
FY20167,371
FY20177,040
FY201816,029
FY20197,724
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20261,792

Top 5 occupations — Charles River Laboratories, Inc.

Top 5 occupations — Deloitte Consulting LLP

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.